Clinical Trial Update: Effect of Dutasteride on HIF-1alpha and VEGF in the Prostate [Phase 4]

View source ↗

Summary

This Phase 4 clinical trial update examined dutasteride in men with benign prostatic hyperplasia, focusing on its effects on HIF-1alpha and VEGF in the prostate…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Prostatic Hyperplasia

Drugs mentioned

• DUTASTERIDE (Dutasteride)

Snippet

Sponsor: Seoul National University Hospital | Conditions: Benign Prostatic Hyperplasia | Phase 4 | Status: COMPLETED